Carlyle Group Inc.

Q1 2021 13F-HR Holdings

Location
Washington, DC
Holdings as of
3/31/2021
Date filed
5/14/2021
Form type
13F-HR
Num holdings
12
Total value ($000)
$13,216
Net value change ($000)
+5,749 (77.0%)
New positions
3
Sold out positions
1
Turnover %
44.5%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Snapshot: Change Analysis

Compared to Q4 2020
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Atotech Ltd 3,112 NEW
Ortho Clinical Diagnostics Holdings plc 2,767 NEW
PPD, Inc. 202 10.6%
TALO 19 46.3%
SMHI 3 100.0%
Vitru Ltd 1 1.1%
SPNT 1 NEW
Top Reduces (Value $000, Stocks/ETFs)
LBRT -153 -52.4%
GTM -130 -2.9%
1Life Healthcare Inc -62 -10.4%
Meta Data Ltd -9 -30.0%
Sirius International Insurance Group, Ltd. -2 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type